Friday 6 November 2026 Export ABT’s income statement to Excel — free account

Abbott Laboratories

ABT Healthcare Medical Devices

Abbott Laboratories' revenue for fiscal 2025 (year ended December 2025) was $44.3 billion, up 5.67% from fiscal 2024.

Revenue: +14.5%
EPS: −43.6%
Free cash flow: +28.9%
Total debt: +140.8%

Quarter to September 2026, against a year earlier

110.08 3.52 −3.10%

Follow ABT

Alert me

Market cap: $196.6B
P/E: 41.1×
Fwd P/E: 35.1×
Dividend yield: 2.29%
F-score: 5/9
Altman Z: 5.61
Beneish M: −2.50
Dividend safety: 62/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Abbott Laboratories 10-K filed Feb 21, 2025

Fiscal year 2024 · Period ended Dec 31, 2024 · Filed Feb 21, 2025 · accepted 4:07 PM ET · Document on sec.gov · Filing index

What changed

Item 1, Business Item 1A, Risk Factors Item 7, Management’s Discussion and Analysis

Item 1, Business: no comparison — no earlier filing on file